Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2004
10/27/2004EP1302459B1 Processes for preparation of fused pyrroles
10/27/2004EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004EP1150952B1 Indole derivatives and their use as mcp-1 receptor antagonists
10/27/2004EP0858996B1 Nerve cell protective agents
10/27/2004CN1541259A Fluorescent diketopyrrolopyrrole analogues
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004CN1539820A Aza aromatic ring substitutional four branched functional molecule material and preparation method
10/27/2004CN1172929C Substituted indoles for modulating NFKB activity
10/27/2004CN1172918C Isothizole derivatives useful anticancer agents
10/27/2004CN1172911C Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/27/2004CN1172672C Alpha-ketoamide multicatalytic protease inhibitors
10/26/2004US6809098 Compounds
10/26/2004US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/21/2004WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents
10/21/2004WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same
10/21/2004WO2004089919A1 Cyclohexanecarboxamido derivative
10/21/2004WO2004089900A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004WO2004089899A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004WO2004089898A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004WO2004089897A1 Compounds having activity at 5ht2c receptor and uses thereof
10/21/2004WO2004089881A1 New sulfonyl derivatives of aminonaphtols
10/21/2004WO2004089877A1 New hydroxynaphthyl amides
10/21/2004WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004WO2004089364A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004WO2004089363A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004WO2004078107A3 Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof
10/21/2004WO2004037181A3 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
10/21/2004US20040210060 Process for the separation of enantiomers and enantiopure reagent
10/21/2004US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid.
10/21/2004US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004US20040209913 Bicyclic Heteroaromatic Alanines
10/21/2004US20040209884 Fused azabicycic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
10/21/2004US20040209876 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
10/21/2004US20040209870 contain 5-HT ligands used to treat central nervous system disorders
10/21/2004US20040209868 Substituted indoles
10/21/2004US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/21/2004CA2522071A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004CA2521989A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004CA2521907A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004CA2521788A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/20/2004EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors
10/20/2004EP1468990A1 Piperazine derivative
10/20/2004EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
10/20/2004EP1468680A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
10/20/2004EP1468001A1 Process for the preparation of 2-or-9-oxa-3,7-diazabicyclo(3.3.1)nonanes from 2-aminomethyl-2,3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION
10/20/2004EP1392659A4 Methods of making indazoles
10/20/2004EP1330457B1 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists
10/20/2004EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators
10/20/2004EP1263725B1 Novel compounds
10/20/2004EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004EP1073440B1 sPLA 2 INHIBITOR ESTERS
10/20/2004EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/20/2004CN1538956A Spiro compounds
10/20/2004CN1538246A Organophotore ceptor with charge transport material having two linked hydrazone group
10/20/2004CN1171855C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril
10/19/2004US6806389 Immobilized transition metal carbonyl complex as a catalyst
10/19/2004US6806357 Fluorous nucleophilic substitution of alcohols and reagents for use therein
10/19/2004US6806285 5-Hydroxyl indole derivatives for treating glaucoma
10/19/2004US6806283 Selective serotonin receptor antagonists and therapeutic applications thereof
10/19/2004US6806264 Arylphenyl-substituted cyclic ketoenols
10/14/2004WO2004088312A2 Fluorescently tagged ligands
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087711A1 Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
10/14/2004WO2004087709A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/14/2004WO2004087658A1 Indolone-acetamide derivatives, processes for preparing them and their uses
10/14/2004WO2004087164A1 8-nitro-tryptanthrin and other tryptanthrin derivatives used for the treatment of diseases caused by highly proliferating cells
10/14/2004WO2004087051A2 Ophthalmic compositions for treating ocular hypertension
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004078708A3 Novel method for synthesising derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylic acid and the use thereof for perindopril synthesis
10/14/2004WO2004078707A3 Novel method for synthesising (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and the use thereof for perindopril synthesis
10/14/2004WO2004070052A3 Compounds and processes for single-pot attachment of a label to nucleic acid
10/14/2004WO2004056727A3 Process of making chalcone derivatives
10/14/2004WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders
10/14/2004US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones
10/14/2004US20040204473 Substituted tricyclics
10/14/2004US20040204448 For inhibiting PDE4(phosphodiesteases) in a mammal; of modulating the production of TNF- alpha; inhibiting matrix metalloproteinases, for therapy of undesired angiogenesis; therapy of cancer
10/14/2004US20040204415 Pyrrolo[1,2-B]pyridazine compounds and their uses
10/14/2004US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine
10/14/2004US20040204407 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
10/14/2004US20040202611 Novel dyes for organ function monitoring
10/14/2004DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4
10/14/2004CA2521113A1 Fluorescently tagged ligands
10/14/2004CA2520899A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/14/2004CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004CA2520568A1 Indolone-acetamide derivatives, processes for preparing them and their uses
10/14/2004CA2519954A1 Benzamide modulators of metabotropic glutamate receptors
10/14/2004CA2519899A1 Ophthalmic compositions for treating ocular hypertension
10/13/2004EP1466891A1 Carboxylic acid derivative
10/13/2004EP1466890A1 Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1465893A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics
10/13/2004EP1465892A1 Glycinamides as factor xa inhibitors
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 458